M&A Deal Summary |
|
|---|---|
| Date | 2024-05-20 |
| Target | Caravel Autism Health |
| Sector | Healthcare Services |
| Buyer(s) | GTCR |
| Sellers(s) | Frazier Healthcare Partners |
| Deal Type | Secondary Buyout |
| Advisor(s) | Harris Williams (Financial) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1980 |
| PE ASSETS | 15.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
GTCR is a private equity firm that typically partners with management when pursuing acquisitions. The Firm looks to grow companies through build-on acquisitions, consolidations, and internal growth. GTCR will consider both equity and mezzanine capital commitments and concentrates its investment activity in consumer products & services, healthcare services, outsourced business services, technology, transaction processing, and pharma/medical products. GTCR was formed in 1980 and is based in Chicago, Illinois.
| DEAL STATS | # |
|---|---|
| Overall | 142 of 157 |
| Sector: Healthcare Services M&A | 24 of 25 |
| Type: Secondary Buyout M&A Deals | 34 of 40 |
| State: Wisconsin M&A | 3 of 3 |
| Country: United States M&A | 137 of 148 |
| Year: 2024 M&A | 2 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-04-25 |
AssetMark
Concord, California, United States AssetMark is a provider of extensive wealth management and technology solutions that power independent financial advisers and their clients. AssetMark provides an end-to-end experience, spanning nearly all elements of an adviser’s engagement with his or her client from initial conversations to ongoing financial planning discussions, including performance reporting and billing. AssetMark is was incorporated in 1996 and is based in Concord, California. |
Buy | $2.7B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-05-29 |
SurModics
Eden Prairie, Minnesota, United States SurModics provides surface modification coating technologies and in vitro diagnostic (IVD) products to the healthcare industry. Its two core businesses include: Medical Device Coatings – lubricious hydrophilic coatings, hemocompatible hydrophilic coatings, and advanced drug delivery systems; and In Vitro Diagnostics (IVD) – immunoassay reagents that improve the performance of in vitro diagnostic tests as well as custom coatings and stabilization products for Molecular Diagnostic applications. Surmodics was founded in 1979 and is based in Eden Prairie, Minnesota. |
Buy | $627M |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1991 |
| PE ASSETS | 3.4B USD |
| Size | Large |
| Type | Sector Focused |
Frazier Healthcare Partners is a private equity and venture capital firm specializing in Growth buyout investment specifically targets businesses that deal Healthcare, Life Sciences, Pharmaceutical services, medical products, and related sectors. Frazier Healthcare Partners was formed in 1991 and is based in Seattle, Washington with an additional office in Palo Alto, California; Boston, Massachusetts; and Menlo Park, California.
| DEAL STATS | # |
|---|---|
| Overall | 28 of 29 |
| Sector: Healthcare Services M&A | 12 of 12 |
| Type: Secondary Buyout M&A Deals | 11 of 12 |
| State: Wisconsin M&A | 1 of 1 |
| Country: United States M&A | 28 of 29 |
| Year: 2024 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-03-12 |
Alcresta Therapeutics
Newton, Massachusetts, United States Alcresta Therapeutics is a specialty pharmaceutical company focusing on discovering and developing a new generation of enzyme-based products that improve digestion and absorption of important nutrients. The company's lead program is a point-of-care, enzyme-based product that improves the bioavailability of long-chain fatty acids (such as DHA, EPA, and AA) for patients with impaired pancreatic output. Compromised pancreatic function is a complication of many diseases such as cystic fibrosis, chronic pancreatitis, and cancer as well as developmental immaturity, and Alcresta's products are aimed at meeting the nutritional needs of these patients. Alcresta Therapeutics was formed in 2011 and is based in Newton, Massachusetts. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-06-25 |
BioMatrix Specialty Pharmacy
Plantation, Florida, United States BioMatrix Specialty Pharmacy offers a comprehensive pharmacy with a wide range of services across hemophilia, transplantation, specialty, and digital health technology solutions. BioMatrix Specialty Pharmacy is a provider for patients with blood disorders, organ transplants and other chronic and acute diseases and conditions. BioMatrix Specialty Pharmacy was founded in 2015 and is based in Plantation, Florida. |
Buy | - |
